Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
71,127.00
64,139.00
62,843.00
60,461.00
56,607.00
55,181.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
71,127.00
64,139.00
62,843.00
60,461.00
56,607.00
55,181.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
222.00
51.00
40.00
50.00
56.00
59.00
General and Administration Expenses
21,251.00
18,972.00
19,436.00
19,249.00
17,958.00
21,773.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
65,293.00
58,806.00
56,342.00
55,352.00
51,811.00
51,571.00
Operating Profit (PBDIT) excl Other Income
5,834.00
5,333.00
6,501.00
5,109.00
4,796.00
3,610.00
Other Income
1,528.00
1,212.00
3,404.00
300.00
9,567.00
31.00
Operating Profit (PBDIT)
10,447.00
8,792.00
12,567.00
8,536.00
17,248.00
7,003.00
Interest
222.00
51.00
40.00
50.00
56.00
59.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
3,085.00
2,247.00
2,662.00
3,127.00
2,885.00
3,362.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
6,991.00
6,192.00
9,862.00
5,357.00
6,163.00
3,575.00
Provision for Tax
1,366.00
1,091.00
2,316.00
1,118.00
1,873.00
861.00
Profit After Tax
5,425.00
5,101.00
7,545.00
4,238.00
4,290.00
2,713.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
191.10
179.95
266.49
150.08
151.22
95.63
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 10.90% vs 2.06% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 9.39% vs -17.97% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 335.29% vs 27.50% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 6.35% vs -32.39% in Mar 2025
Compare Profit and Loss Results of ASKA Pharmaceutical Holdings Co., Ltd.
Figures in Million
consolidated - Profit And Loss Results
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
71,127.00
40,652.00
30,475.00
74.97%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
71,127.00
40,652.00
30,475.00
74.97%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
222.00
131.00
91.00
69.47%
General and Administration Expenses
21,251.00
6,920.00
14,331.00
207.10%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
65,293.00
34,796.00
30,497.00
87.65%
Operating Profit (PBDIT) excl Other Income
5,834.00
5,856.00
-22.00
-0.38%
Other Income
1,528.00
2,883.00
-1,355.00
-47.00%
Operating Profit (PBDIT)
10,447.00
11,640.00
-1,193.00
-10.25%
Interest
222.00
131.00
91.00
69.47%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
3,085.00
2,901.00
184.00
6.34%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
6,991.00
8,608.00
-1,617.00
-18.78%
Provision for Tax
1,366.00
2,793.00
-1,427.00
-51.09%
Profit After Tax
5,425.00
5,763.00
-338.00
-5.87%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
191.1003
180.7155
10.38
5.75%
Profit And Loss - Net Sales
Net Sales 71,127.00 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 10.90% vs 2.06% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5,834.00 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 9.39% vs -17.97% in Mar 2025
Profit And Loss - Interest
Interest 222.00 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 335.29% vs 27.50% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 5,425.00 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 6.35% vs -32.39% in Mar 2025






